RCT Licensing Michigan Pioneer Gene Transfer Technology.Business Editors/Medical Writers
TUCSON, Ariz.--(BW HealthWire)--March 8, 2000
Research Corp. Technologies (RCT RCT Randomized Controlled Trial
RCT Regimental Combat Team (infantry regiment with their own artillery, engineers, medical and tanks)
RCT Rollercoaster Tycoon
RCT Randomized Clinical Trial
RCT Rhondda Cynon Taff ) is offering nonexclusive licenses to a gene transfer system that has become a biotechnology industry standard.
Flexible licensing terms make this valuable genetic tool patented by the University of Michigan (body, education) University of Michigan - A large cosmopolitan university in the Midwest USA. Over 50000 students are enrolled at the University of Michigan's three campuses. The students come from 50 states and over 100 foreign countries. in Ann Arbor Ann Arbor, city (1990 pop. 109,592), seat of Washtenaw co., S Mich., on the Huron River; inc. 1851. It is a research and educational center, with a large number of government and industrial research and development firms, many in high-technology fields such as available to companies of all sizes and in a variety of disciplines.
Michigan received U.S. Patent No. 5,672,344 in September 1997 for a viral-mediated gene transfer system that uses DNA viruses to introduce new genes into mammalian cells.
Although many other techniques are in use today for introducing genes into cells, researchers Drs. William N. Kelley, Thomas Palella and Myron Levine were the first to propose use of viral DNA DNA: see nucleic acid.
or deoxyribonucleic acid
One of two types of nucleic acid (the other is RNA); a complex organic compound found in all living cells and many viruses. It is the chemical substance of genes. vectors as a general way to transfer genes into mammalian cells while working together at Michigan.
They were also the first to directly administer a human gene in vivo in vivo /in vi·vo/ (ve´vo) [L.] within the living body.
Within a living organism.
in vivo adv. and obtain expression in an experimental animal. Their viral-mediated gene transfer system is now a basic technique many companies have adopted over the past decade.
The 1997 patent is based on a parent application Michigan originally filed in 1987. Also, a U.S. patent application is pending with broad claims to viral-based vectors and gene therapy uses.
RCT and Michigan recently signed an agreement assigning the patent and its licensing to RCT. Licensing fees and royalties are based on three fields of use: human gene therapy and DNA vaccines; use in transgenic animals; and general research uses and recombinant protein recombinant protein Molecular biology A protein encoded by recombinant DNA or generated from a recombinant gene. See Recombinant pharmacology. production.
RCT is also responsible for licensing the technology to companies currently using viral-mediated gene transfer systems.
The viral-mediated gene transfer system is the most recent addition to RCT's growing number of systems and components for gene expression that are available for nonexclusive licensing.
The company's Gene Expression Technologies portfolio includes the Pichia Yeast Protein Expression System, the InsectSelect(TM) Insect Cell Expression System, the bovine growth hormone bovine growth hormone
A naturally occurring hormone of cattle that regulates growth and milk production. It may also be produced artificially by genetic engineering techniques and administered to cows to increase milk production. polyadenylation signal sequence and other promoters and enhancers.
Previously, QED QED
Latin quod erat demonstrandum (which was to be demonstrated)
QED which was to be shown or proved [Latin quod erat demonstrandum]
Noun 1. Technologies (http://www.qedtech.com) managed licensing of the gene transfer system for Michigan. The Malvern, Penn., consulting group provides advice and counsel to pharmaceutical, biotechnology, chemical, diagnostic and medical device firms; universities and independent research centers; and investment groups and funds.
For licensing information, contact: Bennett N. Cohen cohen
(Hebrew: “priest”) Jewish priest descended from Zadok (a descendant of Aaron), priest at the First Temple of Jerusalem. The biblical priesthood was hereditary and male. , Ph.D., Director, Commercialization, 520/748-4400, 520/748-0025 fax, E-mail: email@example.com.
RCT (http://www.rctech.com) is an independent technology management company that commercializes technologies from universities and research institutions worldwide. Commercialization vehicles include licensing, partnerships, seed investments and venture development of early-stage technologies.